Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

18:42 07/09/2023

Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.

CITIC SEC: Key Signals and Potential Trends in the Iranian Situation

One of the controlling shareholders of Jiangsu Aidea Pharmaceutical Group (688488.SH), Fu Heliang, intends to increase his shareholding in the company by 10 to 15 million yuan.

Hong Kong stock concept tracking | The US-Iran war triggers violent fluctuations in gold prices, and most investment banks are bullish on the future market (with concept stocks attached)

CITIC SEC: Key Signals and Potential Trends in the Iranian Situation

One of the controlling shareholders of Jiangsu Aidea Pharmaceutical Group (688488.SH), Fu Heliang, intends to increase his shareholding in the company by 10 to 15 million yuan.

Hong Kong stock concept tracking | The US-Iran war triggers violent fluctuations in gold prices, and most investment banks are bullish on the future market (with concept stocks attached)